Catalyst Wire Dossier Catalyst Wire Dossier

Grass pollen SLIT 300 IR

Grass pollen extract (sublingual immunotherapy) · Stallergenes Greer
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Grass pollen SLIT 300 IR, covering 2016-05-25 to 2016-05-25. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy on Phase III Study on 300 IR SLIT to Patients Suffering From Grass Pollen Rhinoconjunctivitis [Phase 3]

See pricing